These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7410380)

  • 1. Solubilization of the platelet plasma membrane serotonin transporter in an active form.
    Talvenheimo J; Rudnick G
    J Biol Chem; 1980 Sep; 255(18):8606-11. PubMed ID: 7410380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization of imipramine-binding protein from human blood platelets.
    Cesura AM; Müller K; Peyer M; Pletscher A
    Eur J Pharmacol; 1983 Dec; 96(3-4):235-42. PubMed ID: 6676106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant binding to the porcine and human platelet serotonin transporters.
    Humphreys CJ; Levin J; Rudnick G
    Mol Pharmacol; 1988 Jun; 33(6):657-63. PubMed ID: 3380080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serotonin transporter-imipramine "receptor".
    Talvenheimo J; Fishkes H; Nelson PJ; Rudnick G
    J Biol Chem; 1983 May; 258(10):6115-9. PubMed ID: 6853478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of lectins with human platelet serotonin transporter.
    Helmeste DM; Chudzik J; Tang SW
    Eur J Pharmacol; 1994 Feb; 266(3):327-31. PubMed ID: 8174615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate and inhibitor binding and translocation by the platelet plasma membrane serotonin transporter.
    Humphreys CJ; Beidler D; Rudnick G
    Biochem Soc Trans; 1991 Feb; 19(1):95-8. PubMed ID: 2037207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Iodoimipramine, a novel ligand for the serotonin transporter.
    Humphreys CJ; Cassel D; Rudnick G
    Mol Pharmacol; 1989 Oct; 36(4):620-6. PubMed ID: 2811859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport.
    Talvenheimo J; Nelson PJ; Rudnick G
    J Biol Chem; 1979 Jun; 254(11):4631-5. PubMed ID: 438209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent affinity labeling, detergent solubilization, and fluid-phase characterization of the rabbit neutrophil formyl peptide chemotaxis receptor.
    Marasco WA; Becker KM; Feltner DE; Brown CS; Ward PA; Nairn R
    Biochemistry; 1985 Apr; 24(9):2227-36. PubMed ID: 3995012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial purification and characterization of the human placental serotonin transporter.
    Ramamoorthy S; Leibach FH; Mahesh VB; Ganapathy V
    Placenta; 1993; 14(4):449-61. PubMed ID: 8248037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization and characterization of [3H]imipramine and [3H]paroxetine binding sites from calf striatum.
    Rotondo A; Giannaccini G; Quattrone C; Marazziti D; Martini C; Cassano GB; Lucacchini A
    Neurochem Res; 1994 Oct; 19(10):1295-300. PubMed ID: 7891847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two affinity states for [3H]imipramine binding to the human platelet 5-hydroxytryptamine carrier: an explanation for the allosteric interaction between 5-hydroxytryptamine and imipramine.
    O'Riordan C; Phillips OM; Williams DC
    J Neurochem; 1990 Apr; 54(4):1275-80. PubMed ID: 2313287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of 5-hydroxytryptamine transport from cholate-disrupted platelet plasma membrane vesicles.
    Rudnick G; Nelson PJ
    Biochemistry; 1978 Nov; 17(24):5300-3. PubMed ID: 728400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
    Mellerup ET; Plenge P; Engelstoft M
    Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet [3H]-imipramine binding by human plasma protein fractions.
    Strijewski A; Chudzik J; Tang SW
    Life Sci; 1988; 42(16):1543-50. PubMed ID: 3352466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of the human placental 5-hydroxytryptamine transporter in a catalytically active form after detergent solubilization.
    Ramamoorthy S; Cool DR; Leibach FH; Mahesh VB; Ganapathy V
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):89-95. PubMed ID: 1520288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin uptake inhibitors differentially modulate high affinity imipramine dissociation in human platelet membranes.
    Wennogle LP; Meyerson LR
    Life Sci; 1985 Apr; 36(16):1541-50. PubMed ID: 3982224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction.
    Segonzac A; Raisman R; Tateishi T; Schoemaker H; Hicks PE; Langer SZ
    J Neurochem; 1985 Feb; 44(2):349-56. PubMed ID: 3871227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand binding to the serotonin transporter: equilibria, kinetics, and ion dependence.
    Humphreys CJ; Wall SC; Rudnick G
    Biochemistry; 1994 Aug; 33(31):9118-25. PubMed ID: 8049215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.